202 related articles for article (PubMed ID: 33208882)
21. Comprehensive study of nine novel cases of TFEB-amplified renal cell carcinoma: an aggressive tumour with frequent PDL1 expression.
Kammerer-Jacquet SF; Gandon C; Dugay F; Laguerre B; Peyronnet B; Mathieu R; Verhoest G; Bensalah K; Leroy X; Aubert S; Vermaut C; Escande F; Verkarre V; Compérat E; Ambrosetti D; Pedeutour F; Belaud-Rotureau MA; Rioux-Leclercq N;
Histopathology; 2022 Aug; 81(2):228-238. PubMed ID: 35562857
[TBL] [Abstract][Full Text] [Related]
22. Histological and molecular characterization of TFEB-rearranged renal cell carcinomas.
Wyvekens N; Rechsteiner M; Fritz C; Wagner U; Tchinda J; Wenzel C; Kuithan F; Horn LC; Moch H
Virchows Arch; 2019 May; 474(5):625-631. PubMed ID: 30706129
[TBL] [Abstract][Full Text] [Related]
23. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion.
Wang XT; Xia QY; Ni H; Ye SB; Li R; Wang X; Shi SS; Zhou XJ; Rao Q
Hum Pathol; 2017 May; 63():190-200. PubMed ID: 28315422
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions.
Martignoni G; Gobbo S; Camparo P; Brunelli M; Munari E; Segala D; Pea M; Bonetti F; Illei PB; Netto GJ; Ladanyi M; Chilosi M; Argani P
Mod Pathol; 2011 Oct; 24(10):1313-9. PubMed ID: 21602817
[TBL] [Abstract][Full Text] [Related]
25. Sclerosing TFEB-rearrangement renal cell carcinoma: a recurring histologic pattern.
Williamson SR; Eble JN; Palanisamy N
Hum Pathol; 2017 Apr; 62():175-179. PubMed ID: 27864122
[TBL] [Abstract][Full Text] [Related]
26. Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC: Interest and Diagnostic Pitfall in Detecting a Paracentric Inversion of TFE3.
Xia QY; Wang XT; Zhan XM; Tan X; Chen H; Liu Y; Shi SS; Wang X; Wei X; Ye SB; Li R; Ma HH; Lu ZF; Zhou XJ; Rao Q
Am J Surg Pathol; 2017 May; 41(5):663-676. PubMed ID: 28288037
[TBL] [Abstract][Full Text] [Related]
27. Renal cell carcinomas with t(6;11)(p21;q12) presenting with tubulocystic renal cell carcinoma-like features.
Rao Q; Zhang XM; Tu P; Xia QY; Shen Q; Zhou XJ; Shi QL
Int J Clin Exp Pathol; 2013; 6(7):1452-7. PubMed ID: 23826432
[TBL] [Abstract][Full Text] [Related]
28. Alpha gene upregulates TFEB expression in renal cell carcinoma with t(6;11) translocation, which promotes cell canceration.
Zhan HQ; Li ST; Shu Y; Liu MM; Qin R; Li YL; Gan L
Int J Oncol; 2018 Mar; 52(3):933-944. PubMed ID: 29328409
[TBL] [Abstract][Full Text] [Related]
29. PSF/SFPQ is a very common gene fusion partner in TFE3 rearrangement-associated perivascular epithelioid cell tumors (PEComas) and melanotic Xp11 translocation renal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity.
Rao Q; Shen Q; Xia QY; Wang ZY; Liu B; Shi SS; Shi QL; Yin HL; Wu B; Ye SB; Li L; Chen JY; Pan MH; Li Q; Li R; Wang X; Zhang RS; Yu B; Ma HH; Lu ZF; Zhou XJ
Am J Surg Pathol; 2015 Sep; 39(9):1181-96. PubMed ID: 26274027
[TBL] [Abstract][Full Text] [Related]
30. MiT family translocation renal cell carcinoma.
Argani P
Semin Diagn Pathol; 2015 Mar; 32(2):103-13. PubMed ID: 25758327
[TBL] [Abstract][Full Text] [Related]
31. Aggressive TFEB-rearranged renal cell carcinoma mimicking chromophobe and clear cell renal cell carcinoma.
Kojima F; Kuroda N; Matsuzaki I; Miyai H; Hara I; Murata SI; Hes O
Pathol Int; 2019 Jan; 69(1):51-53. PubMed ID: 30620430
[No Abstract] [Full Text] [Related]
32. [The translocation carcinoma: A pediatric renal tumor also in adults].
Bruder E; Moch H
Pathologe; 2016 Mar; 37(2):159-65. PubMed ID: 26972595
[TBL] [Abstract][Full Text] [Related]
33. TFEB Rearranged Renal Cell Carcinoma: Pathological and Molecular Characterization of 10 Cases, with Novel Clinical Implications: A Single Center 10-Year Experience.
Wang AX; Tian T; Liu LB; Yang F; He HY; Zhou LQ
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830782
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive study of three novel cases of TFEB-amplified renal cell carcinoma and review of the literature: Evidence for a specific entity with poor outcome.
Mendel L; Ambrosetti D; Bodokh Y; Ngo-Mai M; Durand M; Simbsler-Michel C; Delhorbe M; Amiel J; Pedeutour F
Genes Chromosomes Cancer; 2018 Mar; 57(3):99-113. PubMed ID: 29127730
[TBL] [Abstract][Full Text] [Related]
35. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation.
Davis IJ; Hsi BL; Arroyo JD; Vargas SO; Yeh YA; Motyckova G; Valencia P; Perez-Atayde AR; Argani P; Ladanyi M; Fletcher JA; Fisher DE
Proc Natl Acad Sci U S A; 2003 May; 100(10):6051-6. PubMed ID: 12719541
[TBL] [Abstract][Full Text] [Related]
36. TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations.
Gupta S; Argani P; Jungbluth AA; Chen YB; Tickoo SK; Fine SW; Gopalan A; Al-Ahmadie HA; Sirintrapun SJ; Sanchez A; Hakimi AA; Mcfarlane T; Salazar PA; Williamson SR; Skala SL; Mehra R; Hes O; Antonescu CR; Ladanyi M; Arcila ME; Reuter VE
Am J Surg Pathol; 2019 Nov; 43(11):1445-1461. PubMed ID: 31600176
[TBL] [Abstract][Full Text] [Related]
37. TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management.
Gupta S; Johnson SH; Vasmatzis G; Porath B; Rustin JG; Rao P; Costello BA; Leibovich BC; Thompson RH; Cheville JC; Sukov WR
Mod Pathol; 2017 Jul; 30(7):998-1012. PubMed ID: 28338654
[TBL] [Abstract][Full Text] [Related]
38. Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t(6;11) translocation.
Inamura K; Fujiwara M; Togashi Y; Nomura K; Mukai H; Fujii Y; Yamamoto S; Yonese J; Fukui I; Ishikawa Y
Am J Surg Pathol; 2012 Jan; 36(1):35-42. PubMed ID: 22173116
[TBL] [Abstract][Full Text] [Related]
39. A primary rectal neoplasm with novel DDX5-TFEB fusion.
Zhang M; Yin X; Chen J; Zhu S; Zheng L; Zeng H; Zhou Q; Chen N
Virchows Arch; 2022 Sep; 481(3):511-516. PubMed ID: 35397700
[TBL] [Abstract][Full Text] [Related]
40. [TFEB-amplified renal cell carcinoma. A case report and review of the literature].
Mayoral Guisado C; Gómez Durán Á; Agustín Benítez López D; Toro Zambrano W; Rubio Fernández A; Moreno Ontalba A; Díaz Delgado M
Rev Esp Patol; 2018; 51(4):248-252. PubMed ID: 30269777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]